Literature DB >> 9534280

Determinants of the pulmonary artery pressure rise in left ventricular dysfunction.

C M Tribouilloy1, M Enriquez-Sarano, A Rossi, A J Tajik, J B Seward.   

Abstract

Pulmonary artery hypertension in patients with left ventricular dysfunction is related to poor outcome but the role of cardiac functional abnormalities in the genesis of pulmonary hypertension remains unknown. The aim of this prospective study was to identify the determinants of pulmonary hypertension in 102 consecutive patients with primary left ventricular dysfunction (ejection fraction < 50%). Systolic pulmonary artery pressure was measured by continuous wave Doppler. Left ventricular systolic and diastolic function, severity of functional mitral regurgitation, cardiac output, and left atrial volume were assessed using Doppler echocardiography. In patients with left ventricular dysfunction, systolic pulmonary artery pressure was increased (51 +/- 14 mmHg, range 23 to 87 mmHg). Mitral deceleration time (r = -0.61; p = 0.0001) and mitral effective regurgitant orifice (r = 0.50; p = 0.0001) were the strongest parameters related to systolic pulmonary artery pressure. Multivariate analysis identified these two variables as the strongest predictors of systolic pulmonary artery pressure in association with the mitral E/A ratio (p = 0.006) and age (p = 0.005). In conclusion, pulmonary hypertension is common and variable in patients with left ventricular dysfunction. It is closely related to diastolic dysfunction and severity of functional mitral regurgitation but not independently to the degree of left ventricular systolic dysfunction. These findings underline the importance of assessing diastolic function and quantifying mitral regurgitation in patients with left ventricular dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9534280

Source DB:  PubMed          Journal:  Cardiologia        ISSN: 0393-1978


  6 in total

1.  What is the prognostic significance of pulmonary hypertension in heart failure?

Authors:  Neal A Chatterjee; Gregory D Lewis
Journal:  Circ Heart Fail       Date:  2011-09       Impact factor: 8.790

2.  Approach to patients with heart failure and pulmonary hypertension.

Authors:  Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 3.  Pulmonary hypertension, sleep-disordered breathing, and beta blockers in heart failure patients.

Authors:  Robert P Blankfield
Journal:  Sleep Breath       Date:  2002-12       Impact factor: 2.816

4.  Gene Variant of the Bradykinin B2 Receptor Influences Pulmonary Arterial Pressures in Heart Failure Patients.

Authors:  Thomas P Olson; Robert P Frantz; Stephen T Turner; Kent R Bailey; Christina M Wood; Bruce D Johnson
Journal:  Clin Med Circ Respirat Pulm Med       Date:  2009-02-17

5.  Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography.

Authors:  Justin D Roberts; Paul R Forfia
Journal:  Pulm Circ       Date:  2011 Apr-Jun       Impact factor: 3.017

Review 6.  Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors.

Authors:  Artem Ovchinnikov; Alexandra Potekhina; Evgeny Belyavskiy; Fail Ageev
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.